S.Korea's Hwajin Medical gets FDA sales approval for syringes

HLB Therapeutics Co. announced Thursday that Sofjec, a syringe produced by its subsidiary Hwajin Medical, has been approved for sale by the US Food and Drug Administration (FDA) on the 13th.

The items approved this time are injection needles and disposable syringes supplied by Hwajin.

Hwajin is currently selling syringes to overseas markets including the United States, Saudi Arabia, Vietnam and Mongolia, as well as in Korea.

According to Hwajin, Sofjec is in the form of filter paper attached to a needle, so it prevents the risk of harmful substances from entering the body.

Hwajin Medical is a medical device maker with a 100% stake held by HLB Therapeutics, a new drug development affiliate of the HLB Group.

Write to Jeong Min-nam at peux@hankyung.com